Effective 1 de junio de 2021, medical necessity criteria will be added for the AlloSure Heart and AlloSure Kidney tests for Medicare Advantage plans only. These tests remain not medically necessary for commercial products. Additionally, the information from the policy “Molecular Testing for Chronic Heart Failure and Heart Transplant" has been incorporated into this policy and will therefore be archived. Please refer to the medical policy for more details by clicking here.